CBS News Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.